Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for HIV drugs, according to a lawsuit filed by AIDS activists and unions.
Idaho, Kentucky and 21 other US states have penalised Japanese pharmaceutical firm Teikoku Seiyaku and its subsidiary Teikoku Pharma USA over anti-competitive practices.